Stocks · News reference
8-K filing — Context Therapeutics Inc. (CNTX)
Filed: 2026-07-31 AccNo: 0001628280-26-051399 Size: 153 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Jul 31, 2026, 8:08 PM
- Checked
- Jul 31, 2026, 8:08 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Why SiTime Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
SiTime Corp (SITM) stock rose 30.7% in pre-market trading after beating earnings and sales estimates. Other gainers include CLRO, WYHG, SURG, PAVS, MGRX, CELZ, SOUN, WPP, HNST. YXT was the only loser after CFO resignation.
Read original at benzingaContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move
Context Therapeutics stock fell after hours as Q2 loss widened and the company prioritized its pipeline.
Read original at benzingaContext Therapeutics Q2 EPS $(0.15) Misses $(0.09) Estimate
Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.09) by 66.67 percent. This is a 66.67 percent decrease over losses of $(0.09) per
Read original at benzinga